Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 1Phase 1/2 1

Status

Completed 4Withdrawn 2

Sponsor Class

OTHER 6INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Pancreatic Neoplasms 18Prostatic Neoplasms 10Liver Neoplasms 7Carcinoma, Hepatocellular 6Neoplasm Metastasis 3Lung Neoplasms 3Head and Neck Neoplasms 3Colorectal Neoplasms 3Unresectable Pancreatic Cancer 2Stomach Neoplasms 2Neoplasms 2Lymphatic Metastasis 2Locally Advanced Pancreatic Cancer 2Kidney Neoplasms 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Rectal Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Pancreatic Adenocarcinoma Resectable 1Pancreatic Adenocarcinoma Locally Advanced 1Melanoma 1Liver, Cancer of, Non-Resectable 1Liver Metastasis Colon Cancer 1

Interventions

Sorafenib 131lenvatinib 115Bevacizumab 88Radiosurgery 69atezolizumab 55sintilimab 54Nivolumab 51durvalumab 43Hepatectomy 43Fluorouracil 42apatinib 41Oxaliplatin 41camrelizumab 38Radiofrequency Ablation 38pembrolizumab 36Radiotherapy 36tislelizumab 35Leucovorin 31Magnetic Resonance Spectroscopy 30Immune Checkpoint Inhibitors 28Doxorubicin 28Folfox protocol 26tremelimumab 25regorafenib 25Cisplatin 20spartalizumab 19donafenib 19Gemcitabine 19Cyclophosphamide 19toripalimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Hepatocellular × Electroporation × Clear all
NCT03630640 2024-07-31

NIVOLEP

Assistance Publique - Hôpitaux de Paris

Phase 2 Completed
43 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04404647 2021-03-26

Irreversible Electroporation of Unresectable Liver Tumors

Aalborg University Hospital

Phase NA Withdrawn
Gastrointestinal

Bile Duct Neoplasms, Carcinoma, Hepatocellular

NCT03040453 2020-11-30

IRAL

Karolinska Institutet

Phase NA Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

NCT02828865 2020-07-07

A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers

National Taiwan University Hospital

Phase NA Completed
18 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03008343 2019-09-12

Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
20 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02010801 2013-12-13

Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors

National Taiwan University Hospital

Phase NA Completed
20 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡